
GS-441524 Antiviral Injectables | 20mg/ml | 10ml
CureFIP™ GS-441524 Injectable 20mg/ml, 10ml
What This Product Is
CureFIP™ GS-441524 20mg/ml is the lowest-concentration injectable in our range. It contains the same active antiviral compound — GS-441524 — as our 30mg/ml and 40mg/ml formulations. The total dose of GS-441524 delivered per treatment (measured in mg per kg of body weight) is identical across all three concentrations. Concentration does not determine efficacy. It determines injection volume — and injection volume determines dosing accuracy.
Why Concentration Matters for Small Cats
FIP treatment dosing is calculated in mg of GS-441524 per kg of body weight. In cats weighing under 2.5 kg, the required dose per injection is small in absolute terms. When that small dose is drawn from a high-concentration formulation, the resulting injection volume becomes extremely small — often below the reliable measurement threshold of standard syringes.
A measurement error of 0.05ml in a 0.1ml injection represents a 50% dosing error. In FIP treatment, consistent and accurate dosing across all 84 days of the protocol directly influences treatment outcome. Underdosing extends the time to remission and increases resistance risk. Overdosing creates unnecessary burden on a small cat's physiology.
The 20mg/ml format resolves this by producing a clinically manageable injection volume for cats in the under-2.5 kg weight range, where dosing precision matters most.
Indicated Cases
This formulation is appropriate for:
Adult cats weighing under 2.5 kg
Kittens diagnosed with FIP at any stage
Cats that have lost significant weight during illness and now fall below 2.5 kg
Cases where the attending veterinarian has specified low-concentration formulation for precision dosing
This Formulation Is Not the First Choice For
Cats weighing 2.5 kg or above — the 30mg/ml formulation is more appropriate
Cases requiring high-dose induction protocols — the 40mg/ml formulation is indicated
Clinical Background
GS-441524 is a nucleoside analogue that functions as an RNA-dependent RNA polymerase (RdRp) inhibitor. Following cellular uptake and phosphorylation to its active triphosphate form, it is incorporated into nascent viral RNA chains, causing delayed chain termination and halting feline coronavirus (FCoV/FIPV) replication. The compound was identified as an effective FIP treatment in landmark research published in Nature in 2019 (Pedersen et al.) and has since been evaluated in multiple prospective and retrospective clinical studies across thousands of cases globally.
The 20mg/ml concentration contains the same pharmaceutical-grade GS-441524 as all CureFIP™ injectable formulations. Concentration variation is a manufacturing and clinical precision decision, not a quality distinction.
Concentration Selection Guide
Concentration Primary Indication
20mg/ml (this product) Cats under 2.5 kg · Kittens · Precision low-volume dosing
30mg/ml Cats 2.5–5 kg · Standard FIP cases · First-line treatment 40mg/ml Cats over 5 kg · High-dose protocols · Resistance · Relapse
Administration
Administer subcutaneously once daily. Dose is calculated in mg of GS-441524 per kg of body weight. The standard treatment duration is 84 days of consecutive daily dosing without interruption. Do not adjust dose without veterinary guidance. Use the dosing calculator to determine the correct volume for your cat's current weight.
Treatment response is typically observed within the first 7 days — appetite improvement, reduction in fever, and increased activity are the earliest indicators. If no response is observed within 7 days, contact our clinical support team before discontinuing treatment.
Quality and Sourcing
CureFIP™ injectables are manufactured to pharmaceutical-grade standards with documented API sourcing, concentration verification, and stability testing. Each batch is tested for GS-441524 concentration accuracy before release. We provide full transparency on formulation specifications — contact our team for batch documentation if required for veterinary records.
상품 설명
화학식: C12 H13 N5 O4
농도: 20mg/ml
B12 농도: 50mcg/ml
수량: 1 바이알
순도: 99.4%
pH: 2.2
조성: 에탄올 5%, 프로필렌글리콜 30%, PEG 400 45%, 물 20%.
유통기한: 1년. 바이알은 반드시 실온에서 보관하세요. 냉동실, 냉장고 또는 섭씨 8도(화씨 46도) 미만의 온도에 보관하지 마세요. 원료가 침전되거나 결정화될 수 있습니다.
치료 정보
권장 용량:
• 습식 FIP 고양이 체중 kg당 6mg
• 건식 FIP 고양이 체중 kg당 8mg
• 안구형 FIP 고양이 체중 kg당 10mg
• 신경형 고양이 체중 kg당 10mg
치료 방법: 하루 1회 주사, 주 7일.
치료 기간: 84일 (권장)
참고 자료: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435921/
자주 묻는 질문
치료 기간은 얼마나 되나요?
권장 치료 기간은 12주입니다. 하지만 실제 기간은 고양이가 치료에 얼마나 빨리 반응하는지, FIP 감염의 심각도, 고양이의 품종, 나이, 전반적인 건강 등 여러 요인에 따라 달라질 수 있습니다.
Cure FIP 항바이러스제를 다른 약과 함께 쓸 수 있나요?
네, GS는 항바이러스 치료제로, 고양이의 전반적인 건강을 위해 다른 약과 함께 쓸 수 있습니다. 라이신과 벼룩약은 GS와 함께 쓰는 것을 권장하지 않습니다.
치료 중 무엇을 먹여야 하나요?
갓 익힌 생선, 닭고기, 기타 자연식. 고양이가 설사를 하면 설사가 멈출 때까지 며칠 동안 건사료로 바꾸는 것을 고려하세요.
더 유용한 정보는 자주 묻는 질문 페이지를 확인하세요.
배송 안내
Shipping Time:
2 days to major cities
2 to 4 days to US and Canadian townships.
Shipped from the State of Georgia via FEDEX express services.
Shipping Condition:
Shipped under ambient temperatures. This product is chemically stable at ambient temperatures.
Packaging: Individually packaged in recyclable paper box.
